Consensus Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Delayed NSE India S.E. 06:29:51 2024-03-28 am EDT 5-day change 1st Jan Change
1,621 INR +1.02% Intraday chart for Sun Pharmaceutical Industries Ltd. +3.54% +28.67%

Evolution of the average Target Price on Sun Pharmaceutical Industries Ltd.

Price target over the last 5 years

History of analyst recommendation changes

a46566399fb0.a38Abj7MyJPllR3xuuBXAJBkw1Kex7nLgfa0zotOuDk.EiZNKEe98MWk4k_H6Igwdt8JjCaqr42f56mNjLwU0WBYJkcXSqOJ1Yjzfg~6d290343404e356980b5a2e6a1cf8314
Indian Equities Fall on Monday on Fading Hopes of Early US Rate Cut, Drop in Financial Stocks MT
Jefferies Adjusts Sun Pharmaceutical Industries’ Price Target to INR1,585 From INR1,535, Keeps at Buy MT
Indian Equities Sink on Tuesday Amid Waning Hopes for US Rate Cuts MT
Nomura Adjusts Sun Pharmaceutical Industries' Price Target to INR1,279 From INR1,313, Keeps at Buy MT
Nomura Adjusts Sun Pharmaceutical Industries' Price Target to INR1,313 From INR1,132, Keeps at Buy MT
Jefferies Adjusts Sun Pharmaceutical Industries’ Price Target to INR1,310 From INR1,150, Keeps at Buy MT
Indian shares set to open marginally higher amid global slide RE
Indian Equities Sink on Thursday After US Fed Raises Interest Rates to Highest in 22 Years MT
Nomura Adjusts Sun Pharmaceutical Industries' Price Target to INR1,132 From INR1,190, Keeps at Buy MT
Jefferies Adjusts Sun Pharmaceutical Industries' Price Target to INR1,150 From INR1,200, Keeps at Buy MT
Nomura Adjusts Sun Pharmaceutical’s Price Target to INR1,190 From INR1,094, Keeps at Buy MT
India's Alembic Pharma beats estimates on higher domestic sales RE
Nomura Adjusts Sun Pharmaceutical Industries’ Price Target to 1,010 Indian Rupees From 969 Indian Rupees, Keeps at Buy MT
SUN PHARMACEUTICAL INDUSTRIES : Nomura Adjusts Sun Pharmaceutical Industries' Price Target to 730 Indian Rupees From 623 Indian Rupees, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
37
Last Close Price
1,604 INR
Average target price
1,544 INR
Spread / Average Target
-3.72%
High Price Target
1,790 INR
Spread / Highest target
+11.59%
Low Price Target
1,200 INR
Spread / Lowest Target
-25.19%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Sun Pharmaceutical Industries Ltd.

Jefferies & Co.
Nomura
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings